![]() |
Volumn 23, Issue 6, 2008, Pages 1786-1789
|
Use (or misuse) of vitamin D treatment in CKD and dialysis patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITRIOL;
PARATHYROID HORMONE;
VITAMIN D DERIVATIVE;
ALBRIGHT SYNDROME;
BONE BIOPSY;
CHRONIC KIDNEY DISEASE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MISUSE;
DRUG USE;
HEALTH CARE POLICY;
HEMODIALYSIS PATIENT;
HOMEOSTASIS;
HORMONE RELEASE;
HORMONE SUBSTITUTION;
HORMONE SYNTHESIS;
HUMAN;
HYPERPARATHYROIDISM;
MORTALITY;
NOTE;
OSTEOMALACIA;
PLEIOTROPY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RENAL OSTEODYSTROPHY;
UPREGULATION;
VITAMIN SUPPLEMENTATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MALE;
META-ANALYSIS AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RENAL DIALYSIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
VITAMIN D;
VITAMIN D DEFICIENCY;
|
EID: 44449134355
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfn142 Document Type: Note |
Times cited : (13)
|
References (10)
|